CONCERTA® (methylphenidate HCl) Extended-release Tablets CII

First Page		Document Content
Date: 2009-03-31 14:45:03 Chemistry Organic chemistry Nootropics Piperidines Drug culture Methylphenidate Attention deficit hyperactivity disorder Placebo Pemoline Attention-deficit hyperactivity disorder Medicine Stimulants		CONCERTA® (methylphenidate HCl) Extended-release Tablets CII Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 166,86 KB Share Document on Facebook

	Listing By Classification DocID: 1qDsa - View Document
	prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT DocID: 1pBj0 - View Document
	NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants The NCAA bans classes of drug DocID: 1pvtZ - View Document
	NCAA Guidelines to Document ADHD Treatment with Banned Stimulant Medications Addendum to the January 2009 Guidelines Q & A MarchWhy is the NCAA instituting a stricter application of the medical exception policy DocID: 1oviK - View Document
	prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of DocID: 1ou1z - View Document